Invention Grant
- Patent Title: Anti-transthyretin antibodies
-
Application No.: US16789319Application Date: 2020-02-12
-
Publication No.: US11267878B2Publication Date: 2022-03-08
- Inventor: Tarlochan S. Nijjar , Avijit Chakrabartty , Jeffrey N. Higaki
- Applicant: NEOTOPE NEUROSCIENCE LIMITED , UNIVERSITY HEALTH NETWORK
- Applicant Address: CA Dublin; CA Toronto
- Assignee: NEOTOPE NEUROSCIENCE LIMITED,UNIVERSITY HEALTH NETWORK
- Current Assignee: NEOTOPE NEUROSCIENCE LIMITED,UNIVERSITY HEALTH NETWORK
- Current Assignee Address: CA Dublin; CA Toronto
- Agency: Alston & Bird LLP
- Main IPC: G01N33/68
- IPC: G01N33/68 ; A61K39/00 ; C07K16/18
Abstract:
The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications.
Public/Granted literature
- US20200277361A1 ANTI-TRANSTHYRETIN ANTIBODIES Public/Granted day:2020-09-03
Information query
IPC分类:
